Buys
Open market- Shares
- Avg price
- Total value
Erez Aminov - Chief Executive Officer, Director at MIRA PHARMACEUTICALS, INC.
Issuer-level insider activity
- Role
- Chief Executive Officer, Director
- Issuer ticker
- MIRA on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Erez Aminov in MIRA PHARMACEUTICALS, INC.
Sells
Open market- Shares
- -613,595
- Avg price
- $2.11
- Total value
- -$1,294,685
Net
Past year- Shares
- -613,595
- Share %
- -100%
- Total value
- -$1,294,685
Reported holdings for Erez Aminov in MIRA PHARMACEUTICALS, INC.
Form 4 holding
Chief Executive Officer, Director
MIRA PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 3,592,666
- Estimated value
- $7,580,525
- Report date
- 16 Oct 2025
- Price
- $2.11
- Ownership
- Direct
Form 4 holding
Chief Executive Officer, Director
MIRA PHARMACEUTICALS, INC.
- Security class
- Stock Options (right to buy)
- Shares / value
- 3,155,170
- Estimated value
- Report date
- 17 Dec 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Executive Officer, Director
MIRA PHARMACEUTICALS, INC.
- Security class
- Restricted Stock Units
- Shares / value
- 83,500
- Estimated value
- Report date
- 30 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Erez Aminov in MIRA PHARMACEUTICALS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.